Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Saving money offers numerous benefits, including financial security and peace of mind. Learn how saving can impact your future positively.
13,023 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
If you’re weighing SCHD as a core holding, this guide breaks down what the Schwab U.S. Dividend Equity ETF does, what...
A 20-year-old data analyst managing two jobs, a new gym venture with $80,000 in debt, and a newborn faces a burnout c...
XRP is navigating a critical moment as Ripple deploys AI-driven security testing across the XRP Ledger. The move aims...
Meta is plowing ahead with AI investments. This article explains why the reason meta's spending spree could stay on t...
Is intuitive surgical right now? The robotics leader faces macro headwinds and strong long term demand. This guide br...
Palantir surged into focus after blowout Q1 results and a fresh Buy rating from Argus with a $190 target, raising que...
In a dramatic Q1, a bold Bitcoin-focused strategy posts a $12.5 billion loss. This article explains what happened, wh...
A former antitrust prosecutor who helped litigate the JetBlue-Spirit merger shares lessons for future airline regulat...
Tesla isn’t just selling cars—it's building an autonomy and energy ecosystem. This piece examines whether tesla: wall...
A recent SEC 13F shows Midland Wealth Advisors initiating a stake in Bluerock Private Real Estate Fund. Learn why thi...
Sunrun’s Thursday rally followed a robust first-quarter report, highlighting strong revenue growth and a surge in ene...